Literature DB >> 9952227

Effect of pancreatic juice reflux into biliary tract on N-nitrosobis(2-oxopropyl)amine (BOP)-induced biliary carcinogenesis in Syrian hamsters.

Y Ogura1, S Matsuda, M Usui, N Hanamura, Y Kawarada.   

Abstract

To elucidate the possible role of pancreatic juice reflux into the biliary tract in promoting the development of biliary carcinoma, Syrian hamsters were subjected to cholecystoduodenostomy and ligation of the distal end of the common duct and then subcutaneously injected with N-nitrosobis(2-oxopropyl)amine (BOP) (experimental group). The incidences of gallbladder carcinoma and extrahepatic bile duct carcinoma in the experimental group was significantly higher than in the sham-operated group (P < 0.01, P < 0.05). The proliferating cell nuclear antigen (PCNA) labeling indices of both regions gradually increased with time, and were significantly higher in the experimental group at weeks 9 and 16 than in the sham-operated group at the same time. Trypsin and phospholipase A2 (PLA2) activities in bile and tissue levels of superoxide dismutase (SOD) in the gallbladder and extrahepatic bile ducts were higher in the experimental group than in the sham-operated group. These findings suggest that the carcinogenic effect of BOP was enhanced in biliary epithelium that had proliferated in response to and/or had been injured by activated pancreatic enzymes refluxing into the biliary tract and then increased free radical activity, leading to a high frequency of carcinoma development in the biliary tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952227     DOI: 10.1023/a:1026602216846

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  Biliary cysts.

Authors:  P D Flanigan
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

2.  Induction in hamsters of biliary carcinoma by intracholecystic methylcholanthrene pellets.

Authors:  G O BAIN; P B ALLEN; O SILBERMANN; K KOWALEWSKI
Journal:  Cancer Res       Date:  1959-01       Impact factor: 12.701

3.  Carcinoma of the gallbladder; the experimental induction of primary.

Authors:  J G FORTNER
Journal:  Cancer       Date:  1955 Jul-Aug       Impact factor: 6.860

4.  Tumors of the urinary bladder, gall bladder, and liver in dogs fed o-aminoazotoluene or p-dimethylaminoazobenzene.

Authors:  A A NELSON; G WOODARD
Journal:  J Natl Cancer Inst       Date:  1953-06       Impact factor: 13.506

5.  Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters.

Authors:  W Thamavit; N Bhamarapravati; S Sahaphong; S Vajrasthira; S Angsubhakorn
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

6.  Superoxide dismutase and glutathione peroxidase activities in tumors.

Authors:  A V Peskin; Y M Koen; I B Zbarsky; A A Konstantinov
Journal:  FEBS Lett       Date:  1977       Impact factor: 4.124

7.  Carcinoma of the gallbladder; an attempt at experimental production.

Authors:  G DESFORGES; J DESFORGES; S L ROBBINS
Journal:  Cancer       Date:  1950-11       Impact factor: 6.860

8.  Carcinoma related to choledochal cysts with internal drainage operations.

Authors:  T Todani; Y Watanabe; A Toki; N Urushihara
Journal:  Surg Gynecol Obstet       Date:  1987-01

9.  A case of a rare anomaly of the common bile duct associated with an abnormal arrangement of the pancreaticobiliary ductal union.

Authors:  L E Loria; K Yamamoto; T Eto; T Tomioka; T Miyamoto; N Mochinaga; R Tsuchiya
Journal:  Jpn J Surg       Date:  1988-11

10.  Early lesions of pancreatic ductal carcinoma in the hamster model.

Authors:  P Pour; J Althoff; M Takahashi
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

View more
  1 in total

1.  Imaging hamster model of bile duct cancer in vivo using fluorescent L-glucose derivatives.

Authors:  Hiroshi Yokoyama; Ayako Sasaki; Tadashi Yoshizawa; Hiroshi Kijima; Kenichi Hakamada; Katsuya Yamada
Journal:  Hum Cell       Date:  2016-02-03       Impact factor: 4.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.